Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy. - sprookjes - yvandenbroek - TriplyDB

Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.

Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.

http://www.wikidata.org/entity/Q35075339

about

Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury.

P2860

Q37291351-B32BAB18-2AAC-4031-BE69-6B9A7006E388

P2860

Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.

http://www.wikidata.org/entity/Q35075339

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@ast

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@en

type

label

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@ast

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@en

prefLabel

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@ast

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@en

P1433

Q35075339-8C15AC80-E211-4C3C-8272-09665DBAE3F3

P1476

Q35075339-FDF40433-93FA-45D9-87BC-05A708952C38

P2093

Q35075339-1628A791-95A8-427D-A5D8-CF09CABF32AF

Q35075339-20B5B7C2-5592-4EA3-8570-7ACFDD89C182

Q35075339-353329E2-191A-4DD1-A696-B087666E6DE3

Q35075339-5E89EEC6-3A8E-47D8-A20D-73EEA44CE59E

Q35075339-6734E8F7-D1F9-4363-9549-0D52D0C5395A

Q35075339-D10C6320-3BCD-46AC-AD60-DE909E7C962F

Q35075339-E1291FD8-5BCE-4494-8505-C1EA573767D5

Q35075339-F27195E1-CFFE-4BB3-9EAF-531B3D4CAD06

Q35075339-F86F5579-15F7-4D78-BECB-80C4D3F48785

P2860

Q35075339-04E02EA2-C684-4513-A405-AE81E4EC4134

Q35075339-11C015A5-DF11-4C18-8DEB-1A991A96E7EF

Q35075339-2FE2F3FE-59BC-4581-8DAA-4362D7A1D9CD

Q35075339-3F07484B-F61A-40D7-920F-A6774F86456C

Q35075339-4FE3F493-ADEB-4FAD-9E8E-9DF78912F2F8

Q35075339-62A569B1-C86C-466B-808B-5F44BE4DEBA6

Q35075339-65852740-0AE5-47C4-B199-7109BC61FB02

Q35075339-806AC9CE-316F-4881-B9C6-6B553583C63B

Q35075339-85C76D21-64A8-41BF-9FD9-12839EAA5504

Q35075339-87692E3F-00DF-47C3-B9C3-5870615D5FB9

P304

Q35075339-5589E011-F78E-484A-BFCB-A0A40D2B3E52

P31

Q35075339-50E9C75D-7D1F-46B4-9414-70640D90DD63

P356

Q35075339-894A8BFA-F6A6-4981-9211-647B34D8992A

P407

Q35075339-B2D3E5AC-5927-4F33-8703-F7077504ACDC

P433

Q35075339-BEC2C4F5-DA61-47AF-9701-34A3A7204364

P478

Q35075339-9001D9F6-7DC8-42A1-B805-686402EA154C

P50

Q35075339-1E80CF7B-45EB-45DC-974C-C8EE5B39CD3A

Q35075339-4FFB8FD1-B219-41F3-95EA-9419B31FFDAA

Q35075339-D35B901B-C682-4113-82EA-F9F5433F98CB

P577

Q35075339-6AD47EDE-25A5-4432-BF42-D4A2DE5E44FA

P5875

Q35075339-50A202F2-EBE3-479A-A7FD-CFE9A4A1B84A

P698

Q35075339-DAAB7378-A721-426C-8B40-0ACA5108D7D8

P921

Q35075339-EA1790F0-B7D4-4DD3-A0F8-2C447AAE05E5

P932

Q35075339-C0E18356-6776-4600-B9D2-C4FFB3CA243B

P356

JOURNAL.PONE.0082592

P1433

P1476

Angiopoietins modulate endothe ...... ertrophy after uninephrectomy.

@en

P2093

Chi Ting Su

http://www.w3.org/2001/XMLSchema#string

Ching Fang Wu

http://www.w3.org/2001/XMLSchema#string

Fan Chi Chang

http://www.w3.org/2001/XMLSchema#string

Kuo Shyan Lu

http://www.w3.org/2001/XMLSchema#string

Kwan Dun Wu

http://www.w3.org/2001/XMLSchema#string

Wei Hao Peng

http://www.w3.org/2001/XMLSchema#string

Wen Chih Chiang

http://www.w3.org/2001/XMLSchema#string

Yi Ting Chen

http://www.w3.org/2001/XMLSchema#string

Yung Ming Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

VEGF inhibition and renal thrombotic microangiopathy

Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.

P304

e82592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0082592

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Shuei-Liong Lin

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259457363

http://www.w3.org/2001/XMLSchema#string

P698

24367525

http://www.w3.org/2001/XMLSchema#string

P921

P932

3867364

http://www.w3.org/2001/XMLSchema#string